BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9289598)

  • 1. [Correspondence of the World Health Organization relative to the editorial by T. Ancelle (Med. Trop. 1996; 56: 347-348)].
    Cattand P; Jannin J
    Med Trop (Mars); 1997; 57(1):102-4. PubMed ID: 9289598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correspondence of the French Ministry of Cooperation relative to the editorial by J. Drucker and T. Ancelle (Med. Trop. 1996; 56: 345-346 and 346-348)].
    Bruno JM
    Med Trop (Mars); 1997; 57(1):102, 103. PubMed ID: 9289599
    [No Abstract]   [Full Text] [Related]  

  • 3. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 6. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
    Chappuis F
    Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of sleeping-sickness treatment.
    Pécoul B; Gastellu M
    Lancet; 1999 Sep; 354(9182):955-6. PubMed ID: 10489988
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of human African trypanosomiasis.
    Dumas M; Bouteille B
    Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
    [No Abstract]   [Full Text] [Related]  

  • 10. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 12. Resurrecting the resurrection drug.
    Wickware P
    Nat Med; 2002 Sep; 8(9):908-9. PubMed ID: 12205439
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current therapy of trypanosomiasis].
    Doua F; Boa Yapo F
    Bull Soc Pathol Exot; 1994; 87(5):337-40. PubMed ID: 7496197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A woman with fever and rash after African safari.
    Uslan DZ; Jacobson KM; Kumar N; Berbari EF; Orenstein R
    Clin Infect Dis; 2006 Sep; 43(5):609, 661-2. PubMed ID: 16897839
    [No Abstract]   [Full Text] [Related]  

  • 15. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 17. Availability and affordability of treatment for Human African Trypanosomiasis.
    Etchegorry MG; Helenport JP; Pecoul B; Jannin J; Legros D
    Trop Med Int Health; 2001 Nov; 6(11):957-9. PubMed ID: 11703853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retaking sleeping sickness control in Angola.
    Abel PM; Kiala G; Lôa V; Behrend M; Musolf J; Fleischmann H; Théophile J; Krishna S; Stich A
    Trop Med Int Health; 2004 Jan; 9(1):141-8. PubMed ID: 14728618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 20. Existing chemotherapy and its limitations.
    Gutteridge WE
    Br Med Bull; 1985 Apr; 41(2):162-8. PubMed ID: 3161577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.